Prot# 15201: Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of TRU-015 Administered Intravenously in Subjects with Idiopathic Inflammatory Myopathy (Polymyositis and Dermatomyositis)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/30/05 → 1/4/07

Funding

  • Trubion Pharmaceuticals Inc. (15201)